With 4 currently approved PI3K inhibitors in the market, and countless investments, M&As and candidates entering the clinical stages, the PI3K pathways space has experienced significant growth in recent years.

The PI3K Pathways Digital Summit is the industry’s only meeting dedicated to overcoming the challenges in developing clinically effective next generation PI3K inhibitors.

Join the online discussion at the only digital platform dedicated to bringing together the community of PI3K experts from large pharma, innovative biotech and research institutes for a unique opportunity to address the challenges of the PI3K and AKT pathway, gain clarity on the mTOR signalling pathway and participate in cross-disciplinary discussions with fellow industry peers.